Infectious Mononucleosis: An Updated Review


Cite item

Full Text

Abstract

Background:Infectious mononucleosis is common among adolescents and young adults. Although the majority of cases resolve spontaneously, life-threatening manifestations, and compli- cations have been recognised.

Objective:The purpose of this article is to familiarize clinicians with the clinical manifestations, evaluation, diagnosis, and management of infectious mononucleosis.

Methods:A search was conducted in October 2022 in PubMed Clinical Queries using the key terms \"infectious mononucleosis\" OR "Epstein-Barr virus" OR "EBV". The search strategy included all clinical trials, observational studies, and reviews published within the past 10 years. Only papers published in the English literature were included in this review. The information retrieved from the aforementioned search was used in the compilation of the present article.

Results:Infectious mononucleosis, caused by Epstein-Barr virus, most commonly affects adoles- cents and adults aged 15 to 24 years. Epstein-Barr virus is transmitted primarily in saliva. Infectious mononucleosis is characterized by a triad of fever, tonsillar pharyngitis, and lymphadenopathy. Fa- tigue may be profound but tends to resolve within three months. Periorbital and/or palpebral edema, typically bilateral, occurs in one-third of patients. Splenomegaly and hepatomegaly occur in approx- imately 50% and 10% of cases, respectively. A skin rash, which is usually widely scattered, ery- thematous, and maculopapular, occurs in approximately 10 to 45% of cases. Peripheral blood leu- kocytosis is observed in most patients; lymphocytes make up at least 50% of the white blood cell differential count. Atypical lymphocytes constitute more than 10% of the total lymphocyte count. The classic test for infectious mononucleosis is the demonstration of heterophile antibodies. The monospot test is the most widely used method to detect the serum heterophile antibodies of infectious mononucleosis. When confirmation of the diagnosis of infectious mononucleosis is required in patients with mononucleosis-like illness and a negative mono-spot test, serologic testing for anti- bodies to viral capsid antigens is recommended. Infectious mononucleosis is a risk factor for chronic fatigue syndrome. Spontaneous splenic rupture occurs in 0.1 to 0.5% of patients with infectious mononucleosis and is potentially life-threatening. Treatment is mainly supportive. Reduction of activity and bed rest as tolerated are recommended. Patients should be advised to avoid contact sports or strenuous exercise for 8 weeks or while splenomegaly is still present. Most patients have an uneventful recovery.

Conclusion:Infectious mononucleosis is generally a benign and self-limited disease. Prompt diag- nosis is essential to avoid unnecessary investigations and treatments and to minimize complications. Splenic rupture is the most feared complication. As avoiding exposure to EBV is almost impossible, the most effective way to prevent EBV infection and infectious mononucleosis is the development of an effective, safe, and affordable EBV vaccine that can confer life-long immunity.

About the authors

Alexander Leung

Department of Pediatrics, The University of Calgary, Alberta Children’s Hospital

Author for correspondence.
Email: info@benthamscience.net

Joseph Lam

Department of Pediatrics and Department of Dermatology and Skin Sciences, University of British Columbia

Email: info@benthamscience.net

Benjamin Barankin

Department of Dermatology, Toronto Dermatology Centre

Email: info@benthamscience.net

References

  1. Kuri A, Jacobs BM, Vickaryous N, et al. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United King-dom. BMC Public Health 2020; 20(1): 912. doi: 10.1186/s12889-020-09049-x PMID: 32532296
  2. Leung AKC, Pinto-Rojas A. Infectious Mononucleosis. Consultant 2000; 40: 134-6. doi: 10.25270/con.2022.10.000005
  3. Leung AK. Infectious mononucleosis The Encyclopedia of Molecular Mechanism of disease. Berlin: Springer-Verlag 2009; pp. 1346-7.
  4. Filatov N. Lectures on acute infectious diseases in children. Moscow, Russia 1887; p. 2.
  5. Pfeiffer E. Yearbook of paediatrics and physical education 1889; 29: 257-64.
  6. Sprunt TPV, Evans FA. Mononuclear leukocytosis in reaction to acute infection (infectious mononucleosis). Bulletin Johns Hopkins Hos-pital (Balitmore) 1920; 31: 410-7.
  7. Downey H, McKinlay CA. Acute lymphadenosis compared with acute lymphatic leukemia. Arch Intern Med 1923; 32(1): 82-112. doi: 10.1001/archinte.1923.00110190085006
  8. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt’s lymphoma. Lancet 1964; 283(7335): 702-3. doi: 10.1016/S0140-6736(64)91524-7 PMID: 14107961
  9. Henle G, Henle W, Diehl V. Relation of Burkitt’s tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci USA 1968; 59(1): 94-101. doi: 10.1073/pnas.59.1.94 PMID: 5242134
  10. Aronson MD, Auwaerter PG. Infectious mononucleosis in adults and adolescents. UpToDate
  11. Ebell MH, Call M, Shinholser J, Gardner J. Does this patient have infectious mononucleosis? The rational clinical examination systematic review. JAMA 2016; 315(14): 1502-9. doi: 10.1001/jama.2016.2111 PMID: 27115266
  12. Leung AKC, Wong AH, Leong KF. Infectious mononucleosis: Clinical manifestations, investigations, and management Advances in Health and Disease. New York: Nova Science Publishers, Inc. 2018; Vol. 6: pp. 45-71.
  13. Mohseni M, Boniface MP, Graham C. Mononucleosis. Treasure Island, (FL): StatPearls Publishing 2022.
  14. Mohseni M, Boniface MP, Graham C, Doerr C. Mononucleosis (Nursing). Treasure Island, (FL): StatPearls Publishing 2022.
  15. Correia S, Bridges R, Wegner F, et al. Sequence variation of Epstein-Barr virus: Viral types, geography, codon usage, and diseases. J Virol 2018; 92(22): e01132-18. doi: 10.1128/JVI.01132-18 PMID: 30111570
  16. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician 2004; 70(7): 1279-87. PMID: 15508538
  17. Ellen Rimsza M, Kirk GM. Common medical problems of the college student. Pediatr Clin North Am 2005; 52(1): 9-24. doi: 10.1016/j.pcl.2004.11.002
  18. Becker JA, Smith JA. Return to play after infectious mononucleosis. Sports Health 2014; 6(3): 232-8. doi: 10.1177/1941738114521984 PMID: 24790693
  19. Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician 2015; 91(6): 372-6. PMID: 25822555
  20. Kazama I, Miura C, Nakajima T. Nonsteroidal anti-inflammatory drugs quickly resolve symptoms associated with EBV-induced infectious mononucleosis in patients with atopic predispositions. Am J Case Rep 2016; 17: 84-8. doi: 10.12659/AJCR.895399 PMID: 26874639
  21. Dunmire SK, Hogquist KA, Balfour HH. Infectious Mononucleosis. Curr Top Microbiol Immunol 2015; 390(Pt 1): 211-40. doi: 10.1007/978-3-319-22822-8_9 PMID: 26424648
  22. Marshall-Andon T, Heinz P. How to use the Monospot and other heterophile antibody tests. Arch Dis Child Educ Pract Ed 2017; 102(4): 188-93. doi: 10.1136/archdischild-2016-311526 PMID: 28130396
  23. Balfour HH Jr, Dunmire SK, Hogquist KA. Infectious mononucleosis. Clin Transl Immunology 2015; 4(2): e33. doi: 10.1038/cti.2015.1 PMID: 25774295
  24. Balfour HH Jr. Editorial commentary: Genetics and infectious mononucleosis. Clin Infect Dis 2014; 58(12): 1690-1. doi: 10.1093/cid/ciu206 PMID: 24696239
  25. Hwang AE, Hamilton AS, Cockburn MG, et al. Evidence of genetic susceptibility to infectious mononucleosis: A twin study. Epidemiol Infect 2012; 140(11): 2089-95. doi: 10.1017/S0950268811002457 PMID: 22152594
  26. Rostgaard K, Wohlfahrt J, Hjalgrim H. A genetic basis for infectious mononucleosis: Evidence from a family study of hospitalized cases in Denmark. Clin Infect Dis 2014; 58(12): 1684-9. doi: 10.1093/cid/ciu204 PMID: 24696238
  27. Zhang L, Zhou P, Meng Z, et al. Low uric acid level increases the risk of infectious mononucleosis and this effect is more pronounced in women. Mol Clin Oncol 2017; 7(6): 1039-44. doi: 10.3892/mco.2017.1433 PMID: 29285370
  28. Maghzi H, Ataei B, Khorvash F, Yaran M, Maghzi AH. Association between acute infectious mononucleosis and vitamin D deficiency. Viral Immunol 2016; 29(7): 398-400. doi: 10.1089/vim.2016.0038 PMID: 27505106
  29. Cui X, Snapper CM. Epstein Barr virus: Development of vaccines and immune cell therapy for EBV-associated diseases. Front Immunol 2021; 12: 734471. doi: 10.3389/fimmu.2021.734471 PMID: 34691042
  30. Mendoza N, Diamantis M, Arora A, et al. Mucocutaneous manifestations of Epstein-Barr virus infection. Am J Clin Dermatol 2008; 9(5): 295-305. doi: 10.2165/00128071-200809050-00003 PMID: 18717604
  31. Liu M, Wang X, Zhang L, Feng G, Zeng Y, Wang R, et al. Epidemiological characteristics and disease burden of infectious mononucleosis in hospitalized children in China: A nationwide retrospective study. Virol Sin 2022; 37(5): 637-45. doi: 10.1016/j.virs.2022.07.007
  32. Odame J, Robinson J, Khodai-Booran N, et al. Correlates of illness severity in infectious mononucleosis. Can J Infect Dis Med Microbiol 2014; 25(5): 277-80. doi: 10.1155/2014/514164 PMID: 25371691
  33. Dasari V, Sinha D, Neller MA, Smith C, Khanna R. Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: Emerging strategies for clinical development. Expert Rev Vaccines 2019; 18(5): 457-74. doi: 10.1080/14760584.2019.1605906 PMID: 30987475
  34. Jean-Pierre V, Lupo J, Buisson M, Morand P, Germi R. Main targets of interest for the development of a prophylactic or therapeutic Ep-stein-Barr virus vaccine. Front Microbiol 2021; 12: 701611. doi: 10.3389/fmicb.2021.701611 PMID: 34239514
  35. Mui UN, Haley CT, Vangipuram R, Tyring SK. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and pre-vention. J Am Acad Dermatol 2019; 81(1): 23-41. doi: 10.1016/j.jaad.2018.10.072 PMID: 30502415
  36. Hoover K, Higginbotham K. Epstein Barr virus. Treasure Island, (FL): StatPearls Publishing 2021.
  37. Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol 2018; 102: 84-92. doi: 10.1016/j.jcv.2018.03.001 PMID: 29525635
  38. Israele V, Shirley P, Sixbey JW. Excretion of the Epstein-Barr virus from the genital tract of men. J Infect Dis 1991; 163(6): 1341-3. doi: 10.1093/infdis/163.6.1341 PMID: 1645383
  39. Näher H, Gissmann L, Freese UK, Petzoldt D, Helfrich S. Subclinical Epstein-Barr virus infection of both the male and female genital tract--indication for sexual transmission. J Invest Dermatol 1992; 98(5): 791-3. doi: 10.1111/1523-1747.ep12499958 PMID: 1314867
  40. Rezk E, Nofal YH, Hamzeh A, Aboujaib MF, AlKheder MA, Al Hammad MF. Steroids for symptom control in infectious mononucleosis. Cochrane Libr 2015; 2015(12): CD004402. doi: 10.1002/14651858.CD004402.pub3 PMID: 26558642
  41. Sixbey J, Lemon S, Pagano J. A second site for Epstein-Barr virus shedding: The uterine cervix. Lancet 1986; 328(8516): 1122-4. doi: 10.1016/S0140-6736(86)90531-3 PMID: 2877273
  42. Walter K. Pharyngitis and tonsillar exudates in an 18-year-old woman. JAMA 2021; 326(21): 2195-6. doi: 10.1001/jama.2021.19023 PMID: 34779824
  43. Naughton P, Healy M, Enright F, Lucey B. Infectious Mononucleosis: Diagnosis and clinical interpretation. Br J Biomed Sci 2021; 78(3): 107-16. doi: 10.1080/09674845.2021.1903683 PMID: 33721513
  44. Sullivan JL. Clinical manifestations and treatment of Epstein-Barr virus infection. UpToDate
  45. Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 2011; 24(1): 193-209. doi: 10.1128/CMR.00044-10 PMID: 21233512
  46. Forgie SED, Marrie TJ. Cutaneous eruptions associated with antimicrobials in patients with infectious mononucleosis. Am J Med 2015; 128(1): e1-2. doi: 10.1016/j.amjmed.2014.09.011 PMID: 25261013
  47. Chen Y, Wang H, Liu X, Luo B. A gene expression signature that correlates with CD8+T cell expansion in acute Epstein-Barr virus infec-tion. Acta Virol 2022; 66(3): 216-27. doi: 10.4149/av_2022_303 PMID: 36029087
  48. American Academy of Pediatrics. Epstein-Barr virus infection (infectious mononucleosis)Red Book: 2021-2024 Report of the Committee on Infectious Diseases. (32nd ed.). Kimberlin DW, Barnett ED, Lynfield R, Swayer MH, Eds. Itasca, IL: American Academy of Pediatrics. 2021; pp. 422-5.
  49. Leung AK. Infectious mononucleosis Common Problems in Ambulatory Pediatrics: Specific Clinical Problems. New York: Nova Science Publishers, Inc. 2011; Vol. 1: pp. 313-6.
  50. Worku D, Chang LH, Blyth I. An unusual presentation of glandular fever. Case Rep Infect Dis 2022; 2022: 1-6. doi: 10.1155/2022/5981070 PMID: 35340747
  51. Wu Y, Ma S, Zhang L, et al. Clinical manifestations and laboratory results of 61 children with infectious mononucleosis. J Int Med Res 2020; 48(10) doi: 10.1177/0300060520924550 PMID: 33045888
  52. Schwartzkopf J. Infectious mononucleosis. JAAPA 2018; 31(11): 52-3. doi: 10.1097/01.JAA.0000546488.73851.dd PMID: 30358681
  53. Macsween KF, Higgins CD, McAulay KA, et al. Infectious mononucleosis in university students in the United kingdom: Evaluation of the clinical features and consequences of the disease. Clin Infect Dis 2010; 50(5): 699-706. doi: 10.1086/650456 PMID: 20121570
  54. Bonito FJP, Cerejeira D, Cunha H. Bilateral palpebral edema in a girl. Pediatr Dermatol 2020; 37(1): 211-2. doi: 10.1111/pde.14009 PMID: 31997442
  55. Hoagland RJ. Infectious mononucleosis. Am J Med 1952; 13(2): 158-71. doi: 10.1016/0002-9343(52)90154-X PMID: 12976417
  56. Inokuchi R, Iida H, Ohta F, Nakajima S, Yahagi N. Hoagland sign. Emerg Med J 2014; 31(7): 561. doi: 10.1136/emermed-2013-203197 PMID: 24071946
  57. Louppides S, Kakoullis L, Parpas G, Panos G. Upper eyelid oedema in a patient with pharyngitis/exudative tonsillitis and malaise: Hoa-gland sign in infectious mononucleosis. BMJ Case Rep 2019; 12(12): e233719. doi: 10.1136/bcr-2019-233719 PMID: 31871012
  58. Nakagawa H, Miyata Y, Maekawa M. Infectious mononucleosis with eyelid edema and palatal petechiae. Korean J Intern Med (Korean Assoc Intern Med) 2021; 36(4): 1027-8. doi: 10.3904/kjim.2020.350 PMID: 32872732
  59. Otsuka Y, Kishida M. Hoagland sign: Bilateral upper eyelid oedema. BMJ Case Rep 2022; 15(6): e250857. doi: 10.1136/bcr-2022-250857 PMID: 35732375
  60. Sasaki Y, Ishii T, Maeda T, et al. Sex difference in clinical presentation of patients with infectious mononucleosis caused by Epstein-Barr virus. J Infect Chemother 2020; 26(11): 1181-5. doi: 10.1016/j.jiac.2020.06.009 PMID: 32620422
  61. Leung A, Robson W. Childhood cervical lymphadenopathy. J Pediatr Health Care 2004; 18(1): 3-7. doi: 10.1016/S0891-5245(03)00212-8 PMID: 14722499
  62. Hosey RG, Kriss V, Uhl TL, DiFiori J, Hecht S, Wen DY. Ultrasonographic evaluation of splenic enlargement in athletes with acute infec-tious mononucleosis. Br J Sports Med 2007; 42(12): 974-7. doi: 10.1136/bjsm.2008.050807 PMID: 18801776
  63. McCorkle R, Thomas B, Suffaletto H, Jehle D. Normative spleen size in tall healthy athletes: Implications for safe return to contact sports after infectious mononucleosis. Clin J Sport Med 2010; 20(6): 413-5. doi: 10.1097/JSM.0b013e3181f35fe5 PMID: 21079435
  64. Akiyama Y, Ishikane M, Ohmagari N. Epstein-Barr virus induced skin rash in infectious mononucleosis. IDCases 2021; 26: e01298. doi: 10.1016/j.idcr.2021.e01298 PMID: 34631423
  65. Mori F, Fili L, Barni S, et al. Sensitization to amoxicillin/clavulanic acid may underlie severe rashes in children treated for infectious mon-onucleosis. J Allergy Clin Immunol Pract 2019; 7(2): 728-731.e1. doi: 10.1016/j.jaip.2018.06.022 PMID: 30009989
  66. Ando Y, Senda S, Ono Y. Skin rash following amoxicillin treatment. Eur J Intern Med 2022; 102: 114-5. doi: 10.1016/j.ejim.2022.05.012 PMID: 35577680
  67. Leung AKC, Rafaat M. Eruption associated with amoxicillin in a patient with infectious mononucleosis. Int J Dermatol 2003; 42(7): 553-5. doi: 10.1046/j.1365-4362.2003.01699_1.x PMID: 12839608
  68. Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics 2013; 131(5): e1424-7. doi: 10.1542/peds.2012-1575 PMID: 23589810
  69. Ónodi-Nagy K, Kinyó Á, Meszes A, Garaczi E, Kemény L, Bata-Csörgő Z. Amoxicillin rash in patients with infectious mononucleosis: Evidence of true drug sensitization. Allergy Asthma Clin Immunol 2015; 11(1): 1. doi: 10.1186/1710-1492-11-1 PMID: 25784943
  70. Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother 2017; 51(2): 154-62. doi: 10.1177/1060028016669525 PMID: 27620494
  71. Mergoum AM. Amoxicillin rash in infectious mononucleosis. N Engl J Med 2021; 385(11): 1033. doi: 10.1056/NEJMicm2104358 PMID: 34496177
  72. Fields DA. Methicillin rash in infectious mononucleosis. West J Med 1980; 133(6): 521. PMID: 6451082
  73. Paily R. Quinolone drug rash in a patient with infectious mononucleosis. J Dermatol 2000; 27(6): 405-6. doi: 10.1111/j.1346-8138.2000.tb02192.x PMID: 10920588
  74. Baciewicz AM, Chandra R. Cefprozil-induced rash in infectious mononucleosis. Ann Pharmacother 2005; 39(5): 974-5. doi: 10.1345/aph.1E500 PMID: 15827073
  75. McCloskey GL, Massa MC. Cephalexin rash in infectious mononucleosis. Cutis 1997; 59(5): 251-4. PMID: 9169264
  76. Pendleton N, Mallik LJ, Williams JG. Erythromycin rash in glandular fever. Int J Clin Pract 1989; 43(12): 464-5. doi: 10.1111/j.1742-1241.1989.tb08808.x PMID: 2532924
  77. Banerjee I, Mondal S, Sen S, Tripathi SK, Banerjee G. Azithromycin-induced rash in a patient of infectious mononucleosis - a case report with review of literature. J Clin Diagn Res 2014; 8(8): HD01-2. doi: 10.7860/JCDR/2014/9865.4729 PMID: 25302218
  78. Schissel DJ, Singer D, David-Bajar K. Azithromycin eruption in infectious mononucleosis: A proposed mechanism of interaction. Cutis 2000; 65(3): 163-6. PMID: 10738636
  79. Wargo KA, McConnell V, Jennings M. Amoxicillin/telithromycin-induced rash in infectious mononucleosis. Ann Pharmacother 2005; 39(9): 1577. doi: 10.1345/aph.1G140 PMID: 16046485
  80. LeClaire AC, Martin CA, Hoven AD. Rash associated with piperacillin/tazobactam administration in infectious mononucleosis. Ann Pharmacother 2004; 38(6): 996-8. doi: 10.1345/aph.1D378 PMID: 15113982
  81. Candy B, Hotopf M. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev 2006; (3): CD004402. doi: 10.1002/14651858.CD004402.pub2 PMID: 16856045
  82. Wemel AC, Mayet A, Bellier S, Bigaillon C, Rapp C, Ficko C. Severe infectious mononucleosis in immunocompetent adults. Med Mal Infect 2017; 47(8): 540-5. doi: 10.1016/j.medmal.2017.09.009 PMID: 28987291
  83. De Alwis AC, Kwon S. Lingual tonsillitis: An under-recognised manifestation of infectious mononucleosis. J Paediatr Child Health 2021; 57(3): 459. doi: 10.1111/jpc.15367 PMID: 33728778
  84. Auwaerter PG. Infectious mononucleosis in middle age. JAMA 1999; 281(5): 454-9. doi: 10.1001/jama.281.5.454 PMID: 9952206
  85. Horwitz CA, Henle W, Henle G, Schapiro R, Borken S, Bundtzen R. Infectious mononucleosis in patients aged 40 to 72 years: Report of 27 cases, including 3 without heterophil-antibody responses. Medicine (Baltimore) 1983; 62(4): 256-62. doi: 10.1097/00005792-198307000-00005 PMID: 6308383
  86. Welch JL, Holland D. What elements suggest infectious mononucleosis? Ann Emerg Med 2018; 71(4): 521-2. doi: 10.1016/j.annemergmed.2017.06.014 PMID: 28712603
  87. Cai J, Yuan L, Gao H, Hu B, Gui M. Clinical characteristics and empirical research model of infectious mononucleosis complicated with Mycoplasma pneumoniae or/and Cytomegalovirus infection. Comput Math Methods Med 2021; 2021: 1-5. doi: 10.1155/2021/2867913 PMID: 34804192
  88. Cunha BA, Mickail N, Laguerre M. Babesiosis mimicking Epstein Barr Virus (EBV) infectious mononucleosis: Another cause of false positive monospot tests. J Infect 2012; 64(5): 531-2. doi: 10.1016/j.jinf.2012.01.007 PMID: 22266386
  89. Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: Still challenging after 35 years. J Clin Microbiol 2004; 42(8): 3381-7. doi: 10.1128/JCM.42.8.3381-3387.2004 PMID: 15297472
  90. Klemola E, von Essen R, Henle G, Henle W. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies. J Infect Dis 1970; 121(6): 608-14. doi: 10.1093/infdis/121.6.608 PMID: 4316146
  91. Lennon P, Crotty M, Fenton JE. Infectious mononucleosis. BMJ 2015; 350(apr21 2) h1825. doi: 10.1136/bmj.h1825 PMID: 25899165
  92. Medović R, Igrutinović Z, Radojević-Marjanović R, et al. Clinical and laboratory differences between Epstein-Barr and cytomegalovirus infectious mononucleosis in children. Srp Arh Celok Lek 2016; 144(1-2): 56-62. doi: 10.2298/SARH1602056M PMID: 27276859
  93. Taga K, Taga H, Tosato G. Diagnosis of atypical cases of infectious mononucleosis. Clin Infect Dis 2001; 33(1): 83-8. doi: 10.1086/320889 PMID: 11389499
  94. Gaines H, von Sydow M, Pehrson PO, Lundbegh P. Clinical picture of primary HIV infection presenting as a glandular-fever-like illness. BMJ 1988; 297(6660): 1363-8. doi: 10.1136/bmj.297.6660.1363 PMID: 3146367
  95. Horwitz CA, Henle W, Henle G, et al. Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Am J Med 1977; 63(6): 947-57. doi: 10.1016/0002-9343(77)90550-2 PMID: 204189
  96. Ishii T, Sasaki Y, Maeda T, Komatsu F, Suzuki T, Urita Y. Clinical differentiation of infectious mononucleosis that is caused by Epstein-Barr virus or cytomegalovirus: A single-center case-control study in Japan. J Infect Chemother 2019; 25(6): 431-6. doi: 10.1016/j.jiac.2019.01.012 PMID: 30773381
  97. Karpathios T, Drakonaki S, Zervoudaki A, et al. Arcanobacterium haemolyticum in children with presumed streptococcal pharyngotonsillitis or scarlet fever. J Pediatr 1992; 121(5): 735-7. doi: 10.1016/S0022-3476(05)81903-1 PMID: 1432423
  98. Brown M, Schubert T. Phenytoin hypersensitivity hepatitis and mononucleosis syndrome. J Clin Gastroenterol 1986; 8(4): 469-77. doi: 10.1097/00004836-198608000-00019 PMID: 3093562
  99. Lupton JR, Figueroa P, Tamjidi P, Berberian BJ, Sulica VI. An infectious mononucleosis-like syndrome induced by minocycline: A third pattern of adverse drug reaction. Cutis 1999; 64(2): 91-6. PMID: 10467499
  100. Maquiera E, Yañez S, Fernández L, et al. Mononucleosis-like illness as a manifestation of carbamazepine-induced anticonvulsant hyper-sensitivity syndrome. Allergol Immunopathol (Madr) 1996; 24(2): 87-8. PMID: 8933895
  101. Afonso A, Cachão J, Pinto Junior VL, Gouveia T. Gianotti-Crosti syndrome: A challenging exanthema. BMJ Case Rep 2021; 14(4): e240747. doi: 10.1136/bcr-2020-240747 PMID: 33795277
  102. Chisholm KM, Bohling SD, Tsuchiya KD, Paulson VA. A malignant mimicker: Features of Kikuchi-Fujimoto disease in the pediatric pop-ulation. Pediatr Dev Pathol 2022; 25(5): 538-47. doi: 10.1177/10935266221103882 PMID: 35583198
  103. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illnesses. Am J Med 2007; 120(10): 911.e1-8. doi: 10.1016/j.amjmed.2006.12.011 PMID: 17904463
  104. Leung AKC, Kellner JD. Group A β-hemolytic streptococcal pharyngitis in children. Adv Ther 2004; 21(5): 277-87. doi: 10.1007/BF02850032 PMID: 15727397
  105. Leung AKC, Hon KL, Leong KF, Sergi CM. Measles: A disease often forgotten but not gone. Hong Kong Med J 2018; 24(5): 512-20. doi: 10.12809/hkmj187470 PMID: 30245481
  106. Leung AKC, Hon KL, Leong KF. Rubella (German measles) revisited. Hong Kong Med J 2019; 25(2): 134-41. doi: 10.12809/hkmj187785 PMID: 30967519
  107. Leung AKC, Sergi CM, Lam JM, Leong KF. Gianotti-Crosti syndrome (papular acrodermatitis of childhood) in the era of a viral recrudes-cence and vaccine opposition. World J Pediatr 2019; 15(6): 521-7. doi: 10.1007/s12519-019-00269-9 PMID: 31134587
  108. Leung AKC, Davies HD. Cervical lymphadenitis: Etiology, diagnosis, and management. Curr Infect Dis Rep 2009; 11(3): 183-9. doi: 10.1007/s11908-009-0028-0 PMID: 19366560
  109. Leung TNH, Hon KL, Leung AKC, Group A, Group A. Streptococcus disease in Hong Kong children: An overview. Hong Kong Med J 2018; 24(6): 593-601. doi: 10.12809/hkmj187275 PMID: 30416105
  110. Major-Monfried H, Friedman S, Moerdler S. Hemophagocytic Lymphohistiocytosis. Pediatr Rev 2022; 43(10): 596-8. doi: 10.1542/pir.2021-004985 PMID: 36180536
  111. Tumminello R, Glaspey L, Bhamidipati A, Sheehan P, Patel S. Early disseminated Lyme disease masquerading as mononucleosis: A case report. J Emerg Med 2017; 53(6): e133-5. doi: 10.1016/j.jemermed.2017.09.005 PMID: 29102094
  112. Vishnani R, Malkani R, Topal A, Desai HG. Mononucleosis-like drug rash: An interesting case presentation. J Family Med Prim Care 2014; 3(1): 74-6. doi: 10.4103/2249-4863.130329 PMID: 24791243
  113. Watanabe Y, Mashimo S, Ichige H, Nagata H, Kojima M. Scrub typhus mimicking the clinical course of infectious mononucleosis: A case report. J Rural Med 2021; 16(1): 62-6. doi: 10.2185/jrm.2020-037 PMID: 33442438
  114. Cai X, Ebell MH, Haines L. Accuracy of signs, symptoms, and hematologic parameters for the diagnosis of infectious mononucleosis: A systematic review and meta-analysis. J Am Board Fam Med 2021; 34(6): 1141-56. doi: 10.3122/jabfm.2021.06.210217 PMID: 34772769
  115. Leung AK. More on heterophil antibody tests. Postgrad Med 1985; 77(8): 23. PMID: 3889890
  116. Stuempfig ND, Seroy J. Monospot test. Treasure Island, (FL):: StatPearls Publishing 2021.
  117. Wang EX, Kussman A, Hwang CE. Use of Monospot testing in the diagnosis of infectious mononucleosis in the collegiate studentathlete population. Clin J Sport Med 2022; 32(5): 467-70. doi: 10.1097/JSM.0000000000000996 PMID: 36083325
  118. Al-Jitawi SA, Hakooz BA, Kazimi SM. False positive Monospot test in systemic lupus erythematosus. Rheumatology (Oxford) 1987; 26(1): 71. doi: 10.1093/rheumatology/26.1.71 PMID: 3814978
  119. Pavletic AJ, Marques AR. Early disseminated Lyme disease causing false-positive serology for primary Epstein-Barr virus infection: Re-port of 2 cases. Clin Infect Dis 2017; 65(2): 336-7. doi: 10.1093/cid/cix298 PMID: 28379435
  120. Schumacher HR, Austin RM, Stass SA. False-positive serology in infectious monoucleosis. Lancet 1979; 1(8118): 722. doi: 10.1016/S0140-6736(79)91171-1
  121. Thamcharoen N, Sornprom S, Permpalung N, Hyman CL. False positivity of monospot test in an immunocompetent elderly woman with acute cytomegalovirus infection. Am J Emerg Med 2015; 33(10): 1544.e1-2. doi: 10.1016/j.ajem.2015.07.028 PMID: 26275628
  122. Van Essen GG, Lieverse AG, Sprenger HG, Schirm J, Weits J. False-positive Paul-Bunnell test in HIV seroconversion. Lancet 1988; 332(8613): 747-8. doi: 10.1016/S0140-6736(88)90221-8 PMID: 2901598
  123. Jiang SY, Yang JW, Shao JB, Liao XL, Lu ZH, Jiang H. Real-time polymerase chain reaction for diagnosing infectious mononucleosis in pediatric patients: A systematic review and meta-analysis. J Med Virol 2016; 88(5): 871-6. doi: 10.1002/jmv.24402 PMID: 26455510
  124. Zhang L, Zhou P, Meng Z, et al. Infectious mononucleosis and hepatic function. Exp Ther Med 2018; 15(3): 2901-9. doi: 10.3892/etm.2018.5736 PMID: 29456696
  125. Wang Y, Li J, Ren Y, Zhao H. The levels of liver enzymes and atypical lymphocytes are higher in youth patients with infectious mononu-cleosis than in preschool children. Clin Mol Hepatol 2013; 19(4): 382-8. doi: 10.3350/cmh.2013.19.4.382 PMID: 24459643
  126. Simpson L, Sutherland E, Wilkinson D, Saman R, Edafe O. Infectious mononucleosis - should we routinely assess liver function in acute presentation and follow up? J Laryngol Otol 2022; 1-13. doi: 10.1017/S0022215122000639 PMID: 35465858
  127. Tan ET, Wilkinson D, Edafe O. The utility of liver function tests and abdominal ultrasound in infectious mononucleosis—A systematic review. Clin Otolaryngol 2022; 47(6): 611-9. doi: 10.1111/coa.13965 PMID: 35834363
  128. Bartlett A, Williams R, Hilton M. Splenic rupture in infectious mononucleosis: A systematic review of published case reports. Injury 2016; 47(3): 531-8. doi: 10.1016/j.injury.2015.10.071 PMID: 26563483
  129. Bakal DR, Kasitinon D, Kussman AL, Hwang CE. Splenomegaly from recurrent infectious mononucleosis in an NCAA Division I Athlete. Curr Sports Med Rep 2021; 20(10): 511-3. doi: 10.1249/JSR.0000000000000887 PMID: 34622813
  130. Baker CR, Kona S. Spontaneous splenic rupture in a patient with infectious mononucleosis. BMJ Case Rep 2019; 12(9): e230259. doi: 10.1136/bcr-2019-230259 PMID: 31570350
  131. Barnwell J, Deol PS. Atraumatic splenic rupture secondary to Epstein-Barr virus infection. BMJ Case Rep 2017; 2017: bcr2016218405. doi: 10.1136/bcr-2016-218405 PMID: 28119438
  132. Dessie A, Binder W. Spontaneous rupture of the spleen due to infectious mononucleosis. RI Med J 2017; 100(7): 33-5.
  133. Khoo SG, Ullah I, Manning KP, Fenton JE. Spontaneous splenic rupture in infectious mononucleosis. Ear Nose Throat J 2007; 86(5): 300-1. doi: 10.1177/014556130708600518 PMID: 17580813
  134. Rinderknecht AS, Pomerantz WJ. Spontaneous splenic rupture in infectious mononucleosis: Case report and review of the literature. Pediatr Emerg Care 2012; 28(12): 1377-9. doi: 10.1097/PEC.0b013e318276c78a PMID: 23222107
  135. Ruymbeke H, Schouten J, Sermon F. EBV: Not your everyday benign virus. Acta Gastroenterol Belg 2020; 83(3): 485-7. PMID: 33094599
  136. Sivakumar P, Dubrey SW, Goel S, Adler L, Challenor E. Spontaneous rupture of the spleen resulting from infectious mononucleosis. Br J Hosp Med 2013; 74(11): 652. doi: 10.12968/hmed.2013.74.11.652 PMID: 24220533
  137. Mk S. S S, H VN. Spontaneous splenic rupture in a case of infectious mononucleosis. J Assoc Physicians India 2019; 67(7): 90-2. PMID: 31559784
  138. Sylvester JE, Buchanan BK, Paradise SL, Yauger JJ, Beutler AI. Association of splenic rupture and infectious mononucleosis: A retrospective analysis and review of return-to-play recommendations. Sports Health 2019; 11(6): 543-9. doi: 10.1177/1941738119873665 PMID: 31550435
  139. Chóliz-Ezquerro J, Allué-Cabañuz M, Martínez-Germán A. Hypovolemic shock due to nontraumatic splenic rupture in adolescent patient. A rare complication of infectious mononucleosis. Cir Cir 2021; 89(6): 844-5. doi: 10.24875/CIRU.20000279 PMID: 34851595
  140. Gilmartin S, Hatton S, Ryan J. Teenage kicks: Splenic rupture secondary following infectious mononucleosis. BMJ Case Rep 2019; 12(5): e229030. doi: 10.1136/bcr-2018-229030 PMID: 31133551
  141. Hicks J, Boswell B, Noble V. Traumatic splenic laceration: A rare complication of infectious mononucleosis in an athlete. Curr Sports Med Rep 2021; 20(5): 250-1. doi: 10.1249/JSR.0000000000000840 PMID: 33908910
  142. Kinderknecht JJ. Infectious mononucleosis and the spleen. Curr Sports Med Rep 2002; 1(2): 116-20. doi: 10.1249/00149619-200204000-00009 PMID: 12831720
  143. Lu Q, Fu W, Ouyang G, Xu Q, Huang D. A case of infectious mononucleosis complicated with spontaneous atraumatic splenic rapture caused by Epstein-Barr virus infection. J Med Virol 2022; 94(12): 6127-32. Online ahead of print doi: 10.1002/jmv.28083 PMID: 35996203
  144. Siliézar MM, Muñoz CC, Solano-Iturri JD, et al. Spontaneously ruptured spleen samples in patients with infectious mononucleosis: Anal-ysis of histology and lymphoid subpopulations. Am J Clin Pathol 2018; 150(4): 310-7. doi: 10.1093/ajcp/aqy056 PMID: 30007337
  145. Asgari MM, Begos DG. Spontaneous splenic rupture in infectious mononucleosis: A review. Yale J Biol Med 1997; 70(2): 175-82. PMID: 9493849
  146. Johnson MA, Cooperberg PL, Boisvert J, Stoller JL, Winrob H. Spontaneous splenic rupture in infectious mononucleosis: Sonographic diagnosis and follow-up. AJR Am J Roentgenol 1981; 136(1): 111-4. doi: 10.2214/ajr.136.1.111 PMID: 6779555
  147. Heo DH, Baek DY, Oh SM, Hwang JH, Lee CS, Hwang JH. Splenic infarction associated with acute infectious mononucleosis due to Ep-stein-Barr virus infection. J Med Virol 2017; 89(2): 332-6. doi: 10.1002/jmv.24618 PMID: 27357912
  148. Li Y, George A, Arnaout S, Wang JP, Abraham GM. Splenic infarction: An under-recognized complication of infectious mononucleosis? Open Forum Infect Dis 2018; 5(3): ofy041. doi: 10.1093/ofid/ofy041 PMID: 29577060
  149. Ma Z, Wang Z, Zhang X, Yu H. Splenic infarction after Epstein-Barr virus infection in a patient with hereditary spherocytosis: A case report and literature review. BMC Surg 2022; 22(1): 136. doi: 10.1186/s12893-022-01580-5 PMID: 35397569
  150. Machado C, Melo Salgado J, Monjardino L. The unexpected finding of a splenic infarction in a patient with infectious mononucleosis due to Epstein-Barr virus. BMJ Case Rep 2015; 2015: bcr2015212428. doi: 10.1136/bcr-2015-212428 PMID: 26607191
  151. Naviglio S, Abate MV, Chinello M, Ventura A. Splenic infarction in acute infectious mononucleosis. J Emerg Med 2016; 50(1): e11-3. doi: 10.1016/j.jemermed.2015.09.019 PMID: 26602427
  152. Noor M, Sadough M, Chan S, Singh G. Splenic infarct in a patient with Infectious Mononucleosis: A rare presentation. J Community Hosp Intern Med Perspect 2017; 7(4): 248-50. doi: 10.1080/20009666.2017.1361291 PMID: 29046754
  153. Patruno JV, Milross L, Javaid MM. Not quite a Mono spot diagnosis. Splenic infarction complicating infectious mononucleosis. Am J Med 2021; 134(5): e306-7. doi: 10.1016/j.amjmed.2020.10.025 PMID: 33220284
  154. Pervez H, Tameez Ud Din A, Khan A. A mysterious case of an infarcted spleen due to kissing disease: A rare entity. Cureus 2020; 12(1): e6700. doi: 10.7759/cureus.6700 PMID: 32117651
  155. Minotti B, Reichlin M, Bosbach SJ. Splenic infarction diagnosed by contrast-enhanced ultrasound in infectious mononucleosis - An ap-propriate diagnostic option: A case report with review of the literature. J Med Ultrasound 2022; 30(2): 140-2. doi: 10.4103/jmu.jmu_87_21 PMID: 35832357
  156. Suzuki Y, Kakisaka K, Kuroda H, Sasaki T, Takikawa Y. Splenic infarction associated with acute infectious mononucleosis. Korean J Intern Med (Korean Assoc Intern Med) 2018; 33(2): 451-2. doi: 10.3904/kjim.2016.394 PMID: 28480876
  157. Nishioka H, Hayashi K, Shimizu H. Case report: Splenic infarction in infectious mononucleosis due to Epstein-Barr virus infection. Am J Trop Med Hyg 2022; 106(2): 623-5. doi: 10.4269/ajtmh.21-0943 PMID: 34844205
  158. Harvey JM, Broderick G, Bowie A, et al. Tracking post-infectious fatigue in clinic using routine Lab tests. BMC Pediatr 2016; 16(1): 54. doi: 10.1186/s12887-016-0596-8 PMID: 27118537
  159. Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics 2009; 124(1): 189-93. doi: 10.1542/peds.2008-1879 PMID: 19564299
  160. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. BMJ 2006; 333(7568): 575. doi: 10.1136/bmj.38933.585764.AE PMID: 16950834
  161. Petersen I, Thomas JM, Hamilton WT, White PD. Risk and predictors of fatigue after infectious mononucleosis in a large primary-care cohort. QJM 2006; 99(1): 49-55. doi: 10.1093/qjmed/hci149 PMID: 16330509
  162. Ahmed SI, Aziz K, Gul A, Samar SS, Bareeqa SB. Risk of multiple sclerosis in Epstein-Barr virus infection. Cureus 2019; 11(9): e5699. doi: 10.7759/cureus.5699 PMID: 31720167
  163. Alanazi A. Epstein-Barr virus (EBV) and multiple sclerosis disease: A biomedical diagnosis. Comput Intell Neurosci 2022; 2022: 1-4. doi: 10.1155/2022/3762892 PMID: 36082345
  164. Jons D, Persson Berg L, Sundström P, et al. Follow-up after infectious mononucleosis in search of serological similarities with presymp-tomatic multiple sclerosis. Mult Scler Relat Disord 2021; 56: 103288. doi: 10.1016/j.msard.2021.103288 PMID: 34634626
  165. Läderach F, Münz C. Epstein Barr virus exploits genetic susceptibility to increase multiple sclerosis risk. Microorganisms 2021; 9(11): 2191. doi: 10.3390/microorganisms9112191 PMID: 34835317
  166. Läderach F, Münz C. Altered immune response to the Epstein-Barr virus as a prerequisite for multiple sclerosis. Cells 2022; 11(17): 2757. doi: 10.3390/cells11172757 PMID: 36078165
  167. Loosen SH, Doege C, Meuth SG, Luedde T, Kostev K, Roderburg C. Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany. Front Immunol 2022; 13: 937583. doi: 10.3389/fimmu.2022.937583 PMID: 35983044
  168. Marrie RA, Wolfson C, Sturkenboom MCJM, et al. Multiple sclerosis and antecedent infections. Neurology 2000; 54(12): 2307-10. doi: 10.1212/WNL.54.12.2307 PMID: 10881258
  169. Marrie RA, Wolfson C. Multiple sclerosis and Epstein-Barr virus. Can J Infect Dis 2002; 13(2): 111-8. doi: 10.1155/2002/745764 PMID: 18159380
  170. Münz C. Kissing genetic MS risk loci to life. EBioMedicine 2021; 72: 103594. doi: 10.1016/j.ebiom.2021.103594 PMID: 34563927
  171. Nielsen TR, Rostgaard K, Nielsen NM, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol 2007; 64(1): 72-5. doi: 10.1001/archneur.64.1.72 PMID: 17210811
  172. Tao C, Simpson-Yap S, Taylor B, et al. Markers of Epstein-Barr virus and Human Herpesvirus-6 infection and multiple sclerosis clinical progression. Mult Scler Relat Disord 2022; 59: 103561. doi: 10.1016/j.msard.2022.103561 PMID: 35131728
  173. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis. Ann Neurol 2006; 59(3): 499-503. doi: 10.1002/ana.20820 PMID: 16502434
  174. Xu Y, Hiyoshi A, Smith KA, et al. Association of infectious mononucleosis in childhood and adolescence with risk for a subsequent multiple sclerosis diagnosis among siblings. JAMA Netw Open 2021; 4(10): e2124932. doi: 10.1001/jamanetworkopen.2021.24932 PMID: 34633426
  175. Vindegaard N, Petersen LV, Lyng-Rasmussen BI, Dalsgaard S, Benros ME. Infectious mononucleosis as a risk factor for depression: A nationwide cohort study. Brain Behav Immun 2021; 94: 259-65. doi: 10.1016/j.bbi.2021.01.035 PMID: 33571632
  176. Cheng J. Obstructive sleep apnea (OSA): A complication of acute infectious mononucleosis infection in a child. Int J Pediatr Otorhinolaryngol 2014; 78(3): 562-3. doi: 10.1016/j.ijporl.2013.12.029 PMID: 24480119
  177. Fukumasa H, Tanaka C, Kobayashi M, Hayano S, Amamoto M. Nasopharyngeal airway for upper airway obstruction in infectious mono-nucleosis. Pediatr Int 2020; 62(5): 642-3. doi: 10.1111/ped.14143 PMID: 32346948
  178. He XT, Lee CH, Wu PW, Wang CC. Epstein-Barr virus-associated infectious mononucleosis causing upper airway obstruction in a child with a history of adenoid hypertrophy. Pediatr Neonatol 2020; 61(1): 127-8. doi: 10.1016/j.pedneo.2019.09.010 PMID: 31628027
  179. Lloyd AM, Reilly BK. Infectious mononucleosis and upper airway obstruction: Intracapsular tonsillectomy and adenoidectomy with microdebrider for prompt relief. Ear Nose Throat J 2021; 100(10_suppl (Suppl.): 958S-60S. doi: 10.1177/0145561320930046 PMID: 32511006
  180. Monem SA, O’Connor PF, O’Leary TG. Peritonsillar abscess and infectious mononucleosis: An association or a different presentation of the same condition. Ir Med J 1999; 92(2): 278-80. PMID: 10360113
  181. Piessens P, Indesteege F, Lemkens P. Alice in Wonderland syndrome and upper airway obstruction in infectious mononucleosis. B-ENT 2011; 7(1): 51-4. PMID: 21563558
  182. Sforza E, Hupin D, Roche F. Mononucleosis: A possible cause of idiopathic hypersomnia. Front Neurol 2018; 9: 922. doi: 10.3389/fneur.2018.00922 PMID: 30429823
  183. Wu M, Li SX, Xue P, Zhou J, Tang X. COVID-19 vaccine could trigger the relapse of secondary hypersomnia. Nat Sci Sleep 2021; 13: 2267-71. doi: 10.2147/NSS.S345801 PMID: 35002346
  184. Hasibi M, Zargaran M, Asadollahi-Amin A. Infectious mononucleosis complicated with bilateral peritonsillar abscess and splenic infarc-tion. Case Rep Infect Dis 2021; 2021: 1-4. doi: 10.1155/2021/6623834 PMID: 33777464
  185. Levi JM, Nassif SJ, Shetty K, McKee-Cole KM, Barth PC. A pilot study on pediatric mononucleosis presenting with abscess. Am J Otolaryngol 2020; 41(6): 102716. doi: 10.1016/j.amjoto.2020.102716 PMID: 32979664
  186. Tissot C, Chidiac C, Ader F, Ferry T. Necrotic sore throat, tender lymphadenopathies, hepatitis and activated lymphocytes in circulating blood as a clinical presentation of severe infectious mononucleosis. BMJ Case Rep 2014; 2014(nov20 1) :bcr2014207434. doi: 10.1136/bcr-2014-207434 PMID: 25414230
  187. Yaxley KL. Infectious mononucleosis complicated by peritonsillar abscess and postural orthostatic tachycardia syndrome: A case report SAGE Open Med Case Rep 2020; 8 2050313X20915413. doi: 10.1177/2050313X20915413
  188. Sandman C, Mitchell C. Not just a sore throat: A case of spontaneous tonsillar hemorrhage in acute mononucleosis infection. J Emerg Med 2019; 57(3): e77-9. doi: 10.1016/j.jemermed.2019.05.026 PMID: 31376948
  189. Wahba A, ElBeblawy R. Spontaneous tonsillar hemorrhage due to infectious mononucleosis. Cureus 2020; 12(9): e10367. doi: 10.7759/cureus.10367 PMID: 33062490
  190. Muhammad Hussein, Amir Khalil, Najeeb Rehman, et al. et al. Infectious mononucleosis presenting with loss of taste and smell during the SARS-CoV-2 pandemic? Eur J Case Rep Intern Med 2020; 7(LATEST ONLINE): 002048. doi: 10.12890/2020_002048 PMID: 33313018
  191. Poplin V, McKinsey DS. Arcanobacterium brain abscesses, subdural empyema, and bacteremia complicating Epstein-Barr virus mononu-cleosis. Kans J Med 2018; 11(1): 1-12. PMID: 29844849
  192. Vali Betts E, Gandour-Edwards R. Infectious mononucleosis affecting sinonasal mucosa. Blood 2019; 134(22): 1996. doi: 10.1182/blood.2019002978 PMID: 31778547
  193. Din-Lovinescu C, Berg H. Cervical necrotising fasciitis: A rare complication of infectious mononucleosis. BMJ Case Rep 2019; 12(3): e228172. doi: 10.1136/bcr-2018-228172 PMID: 30826780
  194. Zamor R, Edmunds K, Orscheln E, Duma E. Severe complications from infectious mononucleosis after prolonged steroid therapy. Pediatr Emerg Care 2021; 37(12): e1741-4. doi: 10.1097/PEC.0000000000001940 PMID: 31851074
  195. Bhaskaran PN, Puliyel M, Myers M, Abughali N. Multiple pulmonary nodules in an immunocompetent adolescent with infectious mono-nucleosis. Indian Pediatr 2018; 55(2): 161-2. doi: 10.1007/s13312-018-1251-2 PMID: 29503273
  196. Forsberg M, Galan M, Kra J. Infectious mononucleosis causing acute liver failure and hemolytic anemia in a patient with underlying he-reditary hemochromatosis. Case Rep Oncol 2020; 13(3): 1232-8. doi: 10.1159/000509742 PMID: 33173490
  197. Teijido J, Tillotson K, Liu JM. A rare presentation of Epstein-Barr virus infection. J Emerg Med 2020; 58(2): e71-3. doi: 10.1016/j.jemermed.2019.11.043 PMID: 31973958
  198. Chen JJ, Anand SK, Porter PJ. Infectious mononucleosis with thrombocytopenic purpura. Pediatrics 1968; 41(2): 526-8. doi: 10.1542/peds.41.2.526 PMID: 5688970
  199. Justiz Vaillant AA, Gupta N. ITP-immune thrombocytopenic purpura. Treasure Island, (FL): StatPearls Publishing 2022.
  200. Yusuf H, Kou A, Zelinskas C, et al. Secondary immune thrombocytopenic purpura due to primary Epstein- Barr virus infection. Cureus 2022; 14(6): e26112. doi: 10.7759/cureus.26112 PMID: 35875282
  201. Zhang C, Kelly AM. Severe thrombocytopenia in a case of Epstein-Barr virus-induced infectious mononucleosis. Cureus 2021; 13(9): e17706. doi: 10.7759/cureus.17706 PMID: 34650880
  202. Zhao B, Hou H, Gao R, Tian B, Deng B. Mononucleosis-like illnesses due to co-infection with severe fever with thrombocytopenia syn-drome virus and spotted fever group rickettsia:a case report. BMC Infect Dis 2021; 21(1): 829. doi: 10.1186/s12879-021-06434-8 PMID: 34407756
  203. Massoll AF, Powers SC, Betten DP. Agranulocytosis occurrence following recent acute infectious mononucleosis. Am J Emerg Med 2017; 35(5): 803.e5-6. doi: 10.1016/j.ajem.2016.11.042 PMID: 27912922
  204. Yokoyama T, Tokuhisa Y, Toga A, et al. Agranulocytosis after infectious mononucleosis. J Clin Virol 2013; 56(3): 355-7. doi: 10.1016/j.jcv.2012.11.016 PMID: 23261081
  205. Berlot G, Tomasini A, Zandonà L, Leonardo E, Bussani R, Zarrillo N. Fatal septic shock in a patient with hemophagocytic lymphohistiocytosis associated with an infectious mononucleosis. Case Rep Crit Care 2018; 2018: 1-4. doi: 10.1155/2018/9756050 PMID: 30356381
  206. Hattori A, Hamada Y, Kawabata H, Tanaka K. Acute liver injury secondary to hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection. JGH Open 2021; 5(1): 166-8. doi: 10.1002/jgh3.12439 PMID: 33490632
  207. Kato M, Lee S, Morishita T, et al. Hemophagocytic syndrome due to Epstein-Barr virus and cytomegalovirus coinfection in a patient on adalimumab. J Infect Chemother 2022; 28(6): 823-7. doi: 10.1016/j.jiac.2022.01.018 PMID: 35135708
  208. Kraskovsky V, Harhay J, Mador MJ. Case of haemophagocytic lymphohistiocytosis following Epstein-Barr virus infection. BMJ Case Rep 2021; 14(3): e241222. doi: 10.1136/bcr-2020-241222 PMID: 33789863
  209. Lee AC. Peripheral hemophagocytosis in infectious mononucleosis: Red herring or early warning? J Pediatr Hematol Oncol 2020; 42(7): 446-7. doi: 10.1097/MPH.0000000000001728 PMID: 32000199
  210. Shi J, Chu C, Yu M, et al. Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus. Ital J Pediatr 2021; 47(1): 3. doi: 10.1186/s13052-020-00949-7 PMID: 33413556
  211. Zimmer M, Gill I, Anusim N, Gaikazian SS. Epstein-Barr virus induced haemophagocytic lymphohistiocytosis. BMJ Case Rep 2021; 14(5): e241348. doi: 10.1136/bcr-2020-241348 PMID: 33952568
  212. Chin YY, Chang TCC, Chang CH. Idiopathic pure sudomotor failure and cholinergic urticaria in a patient after acute infectious mononu-cleosis infection. Clin Exp Dermatol 2013; 38(2): 156-9. doi: 10.1111/j.1365-2230.2012.04437.x PMID: 22924754
  213. Vaivanijkul J, Boonsiri K. Conjunctival tumor caused by Epstein-Barr virus-related infectious mononucleosis: Case report and review of literature. Orbit 2017; 36(2): 91-4. doi: 10.1080/01676830.2017.1279659 PMID: 28388350
  214. Iovieno A, Coassin M, Viscogliosi F, Adani C, Cimino L, Fontana L. Delayed-onset bilateral peripheral posterior interstitial keratitis asso-ciated with Epstein-Barr virus-induced infectious mononucleosis. Ocul Immunol Inflamm 2022; 30(2): 290-3. doi: 10.1080/09273948.2020.1811351 PMID: 32946296
  215. Xiao H, Hu B, Luo R, et al. Chronic active Epstein-Barr virus infection manifesting as coronary artery aneurysm and uveitis. Virol J 2020; 17(1): 166. doi: 10.1186/s12985-020-01409-8 PMID: 33121509
  216. Suzuki K, Namba K, Hase K, et al. A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet. Am J Ophthalmol Case Rep 2022; 25: 101363. doi: 10.1016/j.ajoc.2022.101363 PMID: 35146210
  217. Valenzise M, Cucinotta U, Aversa T, Messina MF, Wasniewska M, Pajno GB. Transient hyperthyroidism in a 6-year-old girl with Epstein-Barr virus infection: A link between infectious mononucleosis and autoimmune thyroid disease. J Biol Regul Homeost Agents 2021; 35(1): 349-51. doi: 10.23812/20-374-L PMID: 33634672
  218. Toussirot É, Roudier J. Epstein-Barr virus in autoimmune diseases. Best Pract Res Clin Rheumatol 2008; 22(5): 883-96. doi: 10.1016/j.berh.2008.09.007 PMID: 19028369
  219. Forci B, Novelli A, Sodero A, Sorbi S. Bilateral isolated facial palsy with fast recovery in infectious mononucleosis. Neurol Sci 2017; 38(2): 369-71. doi: 10.1007/s10072-016-2715-6 PMID: 27651385
  220. Joki-Erkkilä VP, Hietaharju A, Dastidar P, Numminen J, Puhakka H. Multiple cranial nerve palsies as a complication of infectious mono-nucleosis due to inflammatory lesion in jugular foramen. Ann Otol Rhinol Laryngol 2000; 109(3): 340-2. doi: 10.1177/000348940010900319 PMID: 10737322
  221. Kennedy M, Apostolova M. A rare case of infectious mononucleosis complicated by Guillain-Barre syndrome. Neurol Int 2013; 5(2): 7. doi: 10.4081/ni.2013.e7 PMID: 23888210
  222. Long CM, Kerschner JE. Parotid mass: Epstein-Barr virus and facial paralysis. Int J Pediatr Otorhinolaryngol 2001; 59(2): 143-6. doi: 10.1016/S0165-5876(01)00472-4 PMID: 11378191
  223. Steiner LA, Erbay A, Pache F, et al. Oculomotor nerve palsy as a presenting symptom of Epstein-Barr virus-associated infectious mono-nucleosis: Case report and review of the literature. Case Rep Neurol 2021; 13(3): 756-62. doi: 10.1159/000520437 PMID: 35082645
  224. Schellinger PD, Sommer C, Leithäuser F, et al. Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host. Ann Neurol 1999; 45(5): 659-62. doi: 10.1002/1531-8249(199905)45:53.0.CO;2-9 PMID: 10319890
  225. Hussain RS, Hussain NA. Ataxia and encephalitis in a young adult with EBV mononucleosis: A case report. Case Rep Neurol Med 2013; 2013: 1-3. doi: 10.1155/2013/516325 PMID: 23781357
  226. Patnaik S, Samal P, Sahoo A, Mohanty B, Turuk J. A fulminant case of Epstein-Barr Virus encephalitis with multiorgan dysfunction. J Neurovirol 2022; 28(3): 464-6. doi: 10.1007/s13365-022-01084-1 PMID: 35796862
  227. Sabat S, Agarwal A, Zacharia T, Labib S, Yousef J. Epstein-Barr virus encephalitis presenting as cerebellar hemorrhage. Neuroradiol J 2015; 28(6): 555-8. doi: 10.1177/1971400915609349 PMID: 26475484
  228. Mohsen H, Abu Zeinah GF, Elsotouhy AH, Mohamed K. Acute disseminated encephalomyelitis following infectious mononucleosis in a toddler. BMJ Case Rep 2013; 2013(jul10 1) bcr 2013010048. doi: 10.1136/bcr-2013-010048 PMID: 23845679
  229. D’Ambrosio E, Khalighinejad F, Ionete C. Intravenous immunoglobulins in an adult case of post-EBV cerebellitis. BMJ Case Rep 2020; 13(2): e231661. doi: 10.1136/bcr-2019-231661 PMID: 32075812
  230. Jason LA, Cotler J, Islam MF, Sunnquist M, Katz BZ. Risks for developing myalgic encephalomyelitis/chronic fatigue syndrome in college students following infectious mononucleosis: A prospective cohort study. Clin Infect Dis 2021; 73(11): e3740-6. doi: 10.1093/cid/ciaa1886 PMID: 33367564
  231. Jason LA, Yoo S, Bhatia S. Patient perceptions of infectious illnesses preceding myalgic encephalomyelitis/chronic fatigue syndrome. Chronic Illn 2021; 17423953211043106. doi: 10.1177/17423953211043106 PMID: 34541918
  232. Jason LA, Cotler J, Islam MF, Furst J, Katz BZ. Predictors for developing severe myalgic encephalomyelitis/chronic fatigue syndrome following infectious mononucleosis. Journal of Rehabilitation Therapy 2022; 4(1): 1-5. doi: 10.29245/2767-5122/2021/1.1129 PMID: 35350440
  233. Greydanus DE, Merrick J. Infectious mononucleosis: Be aware of its lethality! Int J Adolesc Med Health 2019; 31(1): 20180284. doi: 10.1515/ijamh-2018-0284 PMID: 30645196
  234. Maier-Stocker C, Hellwig D, Hanses F. Lemierre’s syndrome following infectious mononucleosis: An unusual reason for neck pain. Lancet Infect Dis 2021; 21(7): 1050. doi: 10.1016/S1473-3099(21)00137-7 PMID: 34174227
  235. Chen JJ, Chang HF, Liu CY, Chen DL. Infectious mononucleosis complicated with acute cerebral infarction: A case Report. Acta Neurol Taiwan 2015; 24(1): 25-9. PMID: 26179687
  236. Abidoye O, Raybon-Rojas E, Ogbuagu H. A rare case of Epstein-Barr virus: Infectious mononucleosis complicated by Guillain-Barré syndrome. Cureus 2022; 14(1): e21085. doi: 10.7759/cureus.21085 PMID: 35165547
  237. Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol 2021; 11: 587380. doi: 10.3389/fimmu.2020.587380 PMID: 33488588
  238. Poole BD, Scofield RH, Harley JB, James JA. Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus. Autoimmunity 2006; 39(1): 63-70. doi: 10.1080/08916930500484849 PMID: 16455583
  239. Wang S, Wang S, Singh S. Development of systemic lupus erythematosus after infectious mononucleosis in a 64-year-old woman. J Investig Med High Impact Case Rep 2020; 8. doi: 10.1177/2324709620961613 PMID: 32964755
  240. Luo H, Yuan Z, Qin B. Case report: Chronic active Epstein-Barr virus infection with subcutaneous nodules and systemic damage. Front Med (Lausanne) 2022; 9: 759834. doi: 10.3389/fmed.2022.759834 PMID: 35433738
  241. Chen J, Konstantinopoulos PA, Satyal S, Telonis J, Blair DC. Just another simple case of infectious mononucleosis? Lancet 2003; 361(9364): 1182. doi: 10.1016/S0140-6736(03)12953-4 PMID: 12686041
  242. Shinozuka J, Awaguni H, Tanaka S, et al. Spontaneous regression of pulmonary nodules presenting as Epstein-Barr virus-related atypical infectious mononucleosis. J Pediatr Hematol Oncol 2016; 38(5): e162-5. doi: 10.1097/MPH.0000000000000562 PMID: 27123664
  243. Avcu G. Acute acalculous cholecystitis due to EBV infection presenting as acute abdomen. J Coll Physicians Surg Pak 2022; 32(5): 662-4. doi: 10.29271/jcpsp.2022.05.662 PMID: 35546706
  244. Boninsegna S, Storato S, Riccardi N, et al. Epstein-Barr Virus (EBV) acute acalculous cholecystitis in an immunocompromised adult pa-tient: A case report and a literature review of a neglected clinical presentation. J Prev Med Hyg 2021; 62(1): E237-42. doi: 10.15167/2421-4248/jpmh2021.62.1.1859 PMID: 34322642
  245. Cameron A, Akilan K, Carr D. Infectious mononucleosis - not always a benign condition: A case report of infectious mononucleosis-associated acute acalculous cholecystitis. CJEM 2019; 21(1): 154-6. doi: 10.1017/cem.2018.15 PMID: 29490709
  246. Harvey KG, Tice JG, Sigal A. Epstein-Barr virus causing clinical jaundice and acute acalculous cholecystitis in a previously healthy 17-year-old girl. Am J Case Rep 2021; 22: e932285. doi: 10.12659/AJCR.932285 PMID: 34642291
  247. Kim A, Yang HR, Moon JS, Chang JY, Ko JS. Epstein-barr virus infection with acute acalculous cholecystitis. Pediatr Gastroenterol Hepatol Nutr 2014; 17(1): 57-60. doi: 10.5223/pghn.2014.17.1.57 PMID: 24749090
  248. Koufakis T, Gabranis I. Another report of acalculous cholecystitis in a Greek patient with infectious mononucleosis: A matter of luck or genetic predisposition? Case Reports Hepatol 2016; 2016: 1-3. doi: 10.1155/2016/6080832 PMID: 26885417
  249. Mazur-Melewska K, Derwich A, Mania A, Kemnitz P, Służewski W, Figlerowicz M. Epstein‐Barr virus infection with acute acalculous cholecystitis in previously healthy children. Int J Clin Pract 2019; 73(9): 1-6. doi: 10.1111/ijcp.13386 PMID: 31243873
  250. Young C, Lampe R. Primary Epstein-Barr virus infection in an adolescent female complicated by acute acalculous cholecystitis. Cureus 2019; 11(6): e5044. doi: 10.7759/cureus.5044 PMID: 31501735
  251. Adidam S, Adidam Venkata S, Benn G, Oppong-Twene P, Delapenha RA. Hepatocellular-cholestatic pattern of liver injury in a patient with infectious mononucleosis. Cureus 2021; 13(12): e20395. doi: 10.7759/cureus.20395 PMID: 35036225
  252. Da Cunha T, Mago S, Bath RK. Epstein-Barr virus reactivation causing cholestatic hepatitis. Cureus 2022; 14(4): e24552. doi: 10.7759/cureus.24552 PMID: 35664414
  253. Herold J, Grimaldo F. Epstein-Barr virus-induced jaundice. Clin Pract Cases Emerg Med 2020; 4(1): 69-71. doi: 10.5811/cpcem.2019.10.45049 PMID: 32064430
  254. Rodrigues Santos L, Silva Cruz M, Veiga Ferraz R, Ferraz Moreira V, Castro A. Jaundice as a rare manifestation of Epstein-Barr virus primary infection. Cureus 2021; 13(6): e15609. doi: 10.7759/cureus.15609 PMID: 34277228
  255. Santos VM. Letter to the editor: Infectious mononucleosis and cholestatic hepatitis. (Acta Med Port.)2018; 31(1): 69. doi: 10.20344/amp.10173
  256. Alli A, Nabil F, Ortiz JF. Infectious mononucleosis: A case report with unusual features and abnormal laboratory findings. Cureus 2021; 13(5): e14790. doi: 10.7759/cureus.14790 PMID: 34094752
  257. Čalkić L, Bajramović-Omeragić L, Mujezinović A. Infectious mononucleosis (Epstein-Barr virus infection) and chronic hepatitis. Med Glas 2019; 16(2) doi: 10.17392/1031-19 PMID: 31257838
  258. Ghosh A, Ghoshal UC, Kochhar R, Ghoshal P, Banerjee PK. Infectious mononucleosis hepatitis: Report of two patients. Indian J Gastroenterol 1997; 16(3): 113-4. PMID: 9248190
  259. Hussaini SH, Pilkington N, Barnes JN. Infectious mononucleosis hepatitis; an unwelcome present for Father Christmas. Acute Med 2013; 12(2): 98-101. doi: 10.52964/AMJA.0296 PMID: 23732134
  260. Ikeda S, Sugihara T, Kihara T, et al. Chronic active Epstein-Barr virus infection indistinguishable from autoimmune hepatitis: A case re-port. Yonago Acta Med 2022; 65(2): 160-5. doi: 10.33160/yam.2022.05.003 PMID: 35611062
  261. Manappallil RG, Mampilly N, Josphine B. Acute hepatitis due to infectious mononucleosis. BMJ Case Rep 2019; 12(8): e229679. doi: 10.1136/bcr-2019-229679 PMID: 31473633
  262. Mu J, Xue D, Li M, Wang T, Ma Q, Dong H. Fatal unexpected death due to X-linked lymphoproliferative disease. Leg Med 2021; 52: 101900. doi: 10.1016/j.legalmed.2021.101900 PMID: 34023582
  263. Zhang C, Cui S, Mao G, Li G. Clinical characteristics and the risk factors of hepatic injury in 221 children with infectious mononucleosis. Front Pediatr 2022; 9: 809005. doi: 10.3389/fped.2021.809005 PMID: 35096718
  264. Accomando S, Restivo GA, Scalzo S, Guardino M, Corsello G, Giuffrè M. Epstein-Barr virus-associated acute pancreatitis: A clinical re-port and review of literature. Ital J Pediatr 2022; 48(1): 160. doi: 10.1186/s13052-022-01352-0 PMID: 36064422
  265. Zhu Z, Yin SJ, Kong ZB, et al. Pancreatitis combined with Epstein-Barr virus-induced infectious mononucleosis. Chin Med J (Engl) 2017; 130(16): 2001-2. doi: 10.4103/0366-6999.211875 PMID: 28776557
  266. Páez-Guillán EM, Campos-Franco J, Alende R, Garitaonaindía Y, González-Quintela A. Transient hypertriglyceridemia: A common finding during Epstein-Barr virus-induced infectious mononucleosis. Lipids Health Dis 2021; 20(1): 177. doi: 10.1186/s12944-021-01603-9 PMID: 34895245
  267. Devereaux CE, Bemiller T, Brann O. Ascites and severe hepatitis complicating Epstein-Barr infection. Am J Gastroenterol 1999; 94(1): 236-40. doi: 10.1111/j.1572-0241.1999.00806.x PMID: 9934763
  268. Tamura S, Maruyama D, Miyagi Maeshima A, et al. Epstein-Barr virus-associated enteropathy as a complication of infectious mononucleosis mimicking peripheral T-cell lymphoma. Intern Med 2013; 52(17): 1971-5. doi: 10.2169/internalmedicine.52.0445 PMID: 23994994
  269. AlMudaiheem FA, Alhabdan S, Alhalafi MS, Alshieban S. An insidious case of infectious mononucleosis presenting with acute appendici-tis diagnosed postoperatively: A case report. J Surg Case Rep 2021; 2021(3): rjab039. doi: 10.1093/jscr/rjab039 PMID: 33732427
  270. Cattaneo L, Milani GP, Lava SA, et al. Visceral serositis in acute Epstein-Barr virus infectious mononucleosis. Minerva Med 2021; 112(3): 415-7. doi: 10.23736/S0026-4806.19.06047-6 PMID: 31638357
  271. Martín-Gómez MA, Caba Molina M, Cruz Caparros G, Guerrero Sánchez E, Caballero González A, Gómez Morales M. Immuno complex mediated acute glomerulonephritis in a patient with infectious mononucleosis. Nefrología 2017; 37(4): 439-41. doi: 10.1016/j.nefroe.2016.11.015 PMID: 28750880
  272. Kien C, Ganta K. An atypical presentation of Epstein-Barr virus associated infectious mononucleosis mistaken for pyelonephritis. Cureus 2020; 12(4): e7583. doi: 10.7759/cureus.7583 PMID: 32399317
  273. Moretti M, Lava SAG, Zgraggen L, et al. Acute kidney injury in symptomatic primary Epstein-Barr virus infectious mononucleosis: Sys-tematic review. J Clin Virol 2017; 91: 12-7. doi: 10.1016/j.jcv.2017.03.016 PMID: 28410496
  274. Acharya R, Zeng X, Upadhyay K. Concomitant nephrotic syndrome and tubulointerstitial nephritis in a child with Epstein-Barr virus mononucleosis. BMJ Case Rep 2021; 14(2): e240108. doi: 10.1136/bcr-2020-240108 PMID: 33541950
  275. Robson WLM, Leung AKC, Kaplan BS. Hemolytic-uremic syndrome. Curr Probl Pediatr 1993; 23(1): 16-33. doi: 10.1016/0045-9380(93)90027-A PMID: 8453889
  276. Hudson L, Perlman SE. Necrotizing genital ulcerations in a premenarcheal female with mononucleosis. Obstet Gynecol 1998; 92(4): 642-4. doi: 10.1016/S0029-7844(98)00027-1 PMID: 9764645
  277. Vatopoulou A, Dinas K, Deligeoroglou E, Papanikolaou A. Genital ulceration in adolescent girls: A diagnostic challenge. J Obstet Gynaecol 2021; 41(6): 994-5. doi: 10.1080/01443615.2020.1852539 PMID: 33645404
  278. Sako K, Kenzaka T, Kumabe A. Epstein-Barr virus-associated infectious mononucleosis with acute epididymitis: A case report. BMC Infect Dis 2022; 22(1): 147. doi: 10.1186/s12879-022-07116-9 PMID: 35144561
  279. Clotet S, Matas L, Pomar V, Casademont J. Acute mediastinitis as a rare complication of an infectious mononucleosis.Enfermedades infecciosas y microbiologia clinica (English ed) 2018; 36(9): 601-2. doi: 10.1016/j.eimce.2018.07.001 PMID: 29269099
  280. Fuller GW, Rao JN. Fulminant descending mediastinitis secondary to infectious mononucleosis. J Surg Case Rep 2018; 2018(8): rjy203. doi: 10.1093/jscr/rjy203 PMID: 30093999
  281. Samuel Markowicz, Serge Cappeliez, Cherifi Soraya, Cherifi S. Infectious mononucleosis resulting in acute necrotizing mediastinitis: A case report and literature review. Eur J Case Rep Intern Med 2020; 7: 001829. doi: 10.12890/2020_001829 PMID: 33194856
  282. Papadopoulou-Legbelou K, Papadopoulou-Alataki E, Fleva A, Spanou S, Pavlitou A, Varlamis G. Cardiac complications and immunophenotypic profile of infectious mononucleosis syndrome in children. Indian Pediatr 2012; 49(3): 195-8. doi: 10.1007/s13312-012-0059-8 PMID: 21992856
  283. Pohlgeers KM, Stumbo JR. Syncope in an Athlete. Curr Sports Med Rep 2016; 15(1): 41-5. doi: 10.1249/JSR.0000000000000227 PMID: 26745170
  284. Bakkalci D, Jia Y, Winter JR, Lewis JEA, Taylor GS, Stagg HR. Risk factors for Epstein Barr virus-associated cancers: A systematic re-view, critical appraisal, and mapping of the epidemiological evidence. J Glob Health 2020; 10(1): 010405. doi: 10.7189/jogh.10.010405 PMID: 32257153
  285. Hjalgrim H, Askling J, Rostgaard K, et al. Characteristics of Hodgkin’s lymphoma after infectious mononucleosis. N Engl J Med 2003; 349(14): 1324-32. doi: 10.1056/NEJMoa023141 PMID: 14523140
  286. Hjalgrim H, Ekström Smedby K, Rostgaard K, et al. Infectious mononucleosis, childhood social environment, and risk of Hodgkin lym-phoma. Cancer Res 2007; 67(5): 2382-8. doi: 10.1158/0008-5472.CAN-06-3566 PMID: 17332371
  287. Saal J, Aboudan B, Brossart P, Heine A. Two cases of EBV infection preceding lymphoma. J Cancer Res Clin Oncol 2022; 148(10): 2929-32. doi: 10.1007/s00432-022-04145-4 PMID: 35732965
  288. Cohen JI, Dropulic L, Hsu AP, et al. Association of GATA2 deficiency with severe primary Epstein-Barr virus (EBV) infection and EBV-associated cancers. Clin Infect Dis 2016; 63(1): 41-7. doi: 10.1093/cid/ciw160 PMID: 27169477
  289. Heng YJ, Love S, DeHart JC, Fingeroth JD, Wulf GM. The association of infectious mononucleosis and invasive breast cancer in The Health of Women (HOW) Study®. Breast Cancer 2022; 29(4): 731-9. doi: 10.1007/s12282-022-01351-3 PMID: 35347575
  290. Kap EJ, Konrad M, Kostev K. Clinical characteristics and sick leave associated with infectious mononucleosis in a real‐world setting in Germany. Int J Clin Pract 2021; 75(10): e14690. doi: 10.1111/ijcp.14690 PMID: 34331837
  291. Vlastarakos PV, Michailidou E. How safe is it to prescribe cephalosporins in patients with infectious mononucleosis? Implications for clinical ENT practice. Turk Otolarengoloji Arsivi/Turkish. Archives of Otolaryngology 2018; 56(3): 183-4. doi: 10.5152/tao.2018.3427 PMID: 30319879
  292. Shephard RJ. Exercise and the athlete with infectious mononucleosis. Clin J Sport Med 2017; 27(2): 168-78. doi: 10.1097/JSM.0000000000000330 PMID: 27347865
  293. Hu S, Belcaro G, Ledda A, et al. Mononucleosis-related fatigue: Supplementary management with Robuvit®. Minerva Pediatr 2018; 70(5): 425-9. doi: 10.23736/S0026-4946.18.05213-1 PMID: 30302988
  294. Lennon P. No new evidence to support the routine use of steroids in the treatment of infectious mononucleosis. Evid Based Med 2016; 21(3): 103. doi: 10.1136/ebmed-2016-110404 PMID: 27099076
  295. Singer-Leshinsky S. CME ARTICLE Pathogenesis, diagnostic testing, and management of mononucleosis. JAAPA 2012; 25(5): 58-62. doi: 10.1097/01720610-201205000-00010 PMID: 22712150
  296. Andersson J, Britton S, Ernberg I, et al. Effect of acyclovir on infectious mononucleosis: A double-blind, placebo-controlled study. J Infect Dis 1986; 153(2): 283-90. doi: 10.1093/infdis/153.2.283 PMID: 3003206
  297. Andrei G, Trompet E, Snoeck R. Novel therapeutics for Epstein−Barr virus. Molecules 2019; 24(5): 997. doi: 10.3390/molecules24050997 PMID: 30871092
  298. De Paor M, O’Brien K, Fahey T, Smith SM. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Libr 2016; 2016(12): CD011487. doi: 10.1002/14651858.CD011487.pub2 PMID: 27933614
  299. Hu H, Deng H, Bi J, et al. Clinical characteristics and effectiveness of antiviral agents in hospitalized children with infectious mononucleosis in China: A multicenter retrospective study. Pediatr Investig 2021; 5(3): 188-94. doi: 10.1002/ped4.12294 PMID: 34589674
  300. Pagano JS, Sixbey JW, Lin JC. Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother 1983; 12 (Suppl. B): 113-21. doi: 10.1093/jac/12.suppl_B.113
  301. Pagano J, Whitehurst C, Andrei G. Antiviral Drugs for EBV. Cancers 2018; 10(6): 197. doi: 10.3390/cancers10060197 PMID: 29899236
  302. Zhang S, Zhu Y, Jin Y, Sun H, Wang W, Zhan L. Difference between acyclovir and ganciclovir in the treatment of children with Epstein-Barr virus-associated infectious mononucleosis. Evid Based Complement Alternat Med 2021; 2021: 1-6. doi: 10.1155/2021/8996934 PMID: 34721648
  303. Balfour HH Jr, Sifakis F, Sliman JA, Knight JA, Schmeling DO, Thomas W. Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. J Infect Dis 2013; 208(8): 1286-93. doi: 10.1093/infdis/jit321 PMID: 23868878
  304. Balfour HH Jr, Meirhaeghe MR, Stancari AL, Geris JM, Condon LM, Cederberg LE. Declining Epstein-Barr virus antibody prevalence in college freshmen strengthens the rationale for a prophylactic EBV vaccine. Vaccines 2022; 10(9): 1399. doi: 10.3390/vaccines10091399 PMID: 36146477
  305. Fourcade G, Germi R, Guerber F, et al. Evolution of EBV seroprevalence and primary infection age in a French hospital and a city labora-tory network, 2000-2016. PLoS One 2017; 12(4): e0175574. doi: 10.1371/journal.pone.0175574 PMID: 28414725
  306. Takeuchi K, Tanaka-Taya K, Kazuyama Y, et al. Prevalence of Epstein-Barr virus in Japan: Trends and future prediction. Pathol Int 2006; 56(3): 112-6. doi: 10.1111/j.1440-1827.2006.01936.x PMID: 16497243
  307. Maple PA, Ascherio A, Cohen JI, et al. The Potential for EBV vaccines to prevent multiple sclerosis. Front Neurol 2022; 13: 887794. doi: 10.3389/fneur.2022.887794 PMID: 35812097
  308. Balfour HH Jr. Progress, prospects, and problems in Epstein-Barr virus vaccine development. Curr Opin Virol 2014; 6: 1-5. doi: 10.1016/j.coviro.2014.02.005 PMID: 24632197
  309. Cai J, Zhang B, Li Y, et al. Prophylactic and therapeutic EBV vaccines: Major scientific obstacles, historical progress, and future direction. Vaccines 2021; 9(11): 1290. doi: 10.3390/vaccines9111290 PMID: 34835222
  310. Dasari V, Bhatt KH, Smith C, Khanna R. Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: Challenges and opportunities. Expert Rev Vaccines 2017; 16(4): 377-90. doi: 10.1080/14760584.2017.1293529 PMID: 28276306
  311. Escalante GM, Mutsvunguma LZ, Muniraju M, Rodriguez E, Ogembo JG. Four decades of prophylactic EBV vaccine research: A system-atic review and historical perspective. Front Immunol 2022; 13: 867918. doi: 10.3389/fimmu.2022.867918 PMID: 35493498
  312. Sun C, Chen X, Kang Y, Zeng M. The status and prospects of Epstein-Barr virus prophylactic vaccine development. Front Immunol 2021; 12: 677027. doi: 10.3389/fimmu.2021.677027 PMID: 34168649
  313. Moutschen M, Léonard P, Sokal EM, et al. Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults. Vaccine 2007; 25(24): 4697-705. doi: 10.1016/j.vaccine.2007.04.008 PMID: 17485150
  314. Rees L, Tizard EJ, Morgan AJ, et al. A phase I trial of epstein-barr virus gp350 vaccine for children with chronic kidney disease awaiting transplantation. Transplantation 2009; 88(8): 1025-9. doi: 10.1097/TP.0b013e3181b9d918 PMID: 19855249
  315. Sokal EM, Hoppenbrouwers K, Vandermeulen C, et al. Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, random-ized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 2007; 196(12): 1749-53. doi: 10.1086/523813 PMID: 18190254
  316. Rozman M, Korać P, Jambrosic K, Židovec Lepej S. Progress in prophylactic and therapeutic EBV vaccine development based on molecular characteristics of EBV target antigens. Pathogens 2022; 11(8): 864. doi: 10.3390/pathogens11080864 PMID: 36014985
  317. Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci 2020; 77(21): 4315-24. doi: 10.1007/s00018-020-03538-3 PMID: 32367191
  318. Tangye SG, Palendira U, Edwards ESJ. Human immunity against EBV-lessons from the clinic. J Exp Med 2017; 214(2): 269-83. doi: 10.1084/jem.20161846 PMID: 28108590
  319. A study of an Epstein-Barr virus (EBV) candidate vaccine, mRNA-1189, in 18- to 30-year-oldhealthy adults Available online at:https://clinicaltrialsgov/ct2/history/NCT05164094?V_1=ViewAccessed on November 16, 2022320 Safety and immunogenicity of Epstein-Barr virus (EBV) gp350-ferritin nanoparticle vaccine inadults with or without EBV infection Available online at: https:/ results/NCT04645147 Accessed on November 16, 2022
  320. https://clinicaltrials.gov/ct2/show/
  321. Zhang XY, Teng QB. Recurrence of infectious mononucleosis in adults after remission for 3 years: A case report. World J Clin Cases 2022; 10(12): 3951-8. doi: 10.12998/wjcc.v10.i12.3951 PMID: 35647138
  322. Avgil M, Diav-Citrin O, Shechtman S, Arnon J, Wajnberg R, Ornoy A. Epstein-Barr virus infection in pregnancy—A prospective con-trolled study. Reprod Toxicol 2008; 25(4): 468-71. doi: 10.1016/j.reprotox.2008.04.004 PMID: 18534816

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2024 Bentham Science Publishers